Lifeline Biotechnologies, Inc.
LLBO
Rank in Stocks
#32297
Lifeline Biotechnologies, Inc. operates as a medical technology company in the... Lifeline Biotechnologies, Inc. operates as a medical technology company in the United States. Its technologies focus on prevention, early diagnosis, and quick recovery of various diseases. The company offers First Warning System, a non-invasive, non-compressive, and non-radiogenic device used in assisting the early discovery of breast tissue abnormalities in women. It also provides Mastascope, a hand held endoscope designed to enter the breast nipple via one of its milk ducts, thus permitting the physician to visualize the interior aspects of the breast; and OVASCOPE, an ultra slim endoscope to directly visualize the ovarian surface in the search for cancer. The company also has operations in Europe. Lifeline Biotechnologies, Inc. was incorporated in 1981 and is headquartered in Reno, Nevada.
Share Price
$0.0004
Last synced: 2026-11-13
Market Cap
$1.74M
Change (1 day)
33.33%
Change (1 year)
-55.56%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Lifeline Biotechnologies, Inc. (LLBO)
Category
Healthcare
Operating Margin for Lifeline Biotechnologies, Inc. (LLBO)
Operating Margin as of November 2026 TTM: 0.00%
According to Lifeline Biotechnologies, Inc.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for Lifeline Biotechnologies, Inc. from 2015 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2018 | 0.00% | -100.00% |
| 2017 | 69.12% | 598.18% |
| 2016 | 9.90% | 146.27% |
| 2015 | 4.02% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 18.91% | - |
IE
|
|
| 10.95% | - |
CN
|
|
| 25.26% | - |
CH
|
|
| 13.54% | - |
CH
|
|
| 38.62% | - |
CN
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Lifeline Biotechnologies, Inc.'s operating margin
What was Lifeline Biotechnologies, Inc.'s operating margin in 2025?
In 2025, Lifeline Biotechnologies, Inc.'s operating margin was 0.00%, compared with 0.00% in 2024.
How has Lifeline Biotechnologies, Inc.'s operating margin changed since 2022?
From 2022 to 2025, Lifeline Biotechnologies, Inc.'s operating margin was highest in 2025 (0.00%) and lowest in 2025 (0.00%).
How does Lifeline Biotechnologies, Inc.'s operating margin compare with similar companies?
Lifeline Biotechnologies, Inc.'s operating margin (0.00%) is lower than that of all 5 similar companies listed above. The highest among them is Jafron Biomedical Co.,Ltd., with 38.62%.